Product Name: Estrogen Receptor alpha antibody [ER506]
Applications: FACS, IHC-P
Predicted Target Size:
Positive Controls:
Form Supplied: Liquid
Concentration:
Purification: Ab purified from Bioreactor Concentrate by Protein A/G
Full Name: estrogen receptor 1
Background: This gene encodes an estrogen receptor, a ligand-activated transcription factor composed of several domains important for hormone binding, DNA binding, and activation of transcription. The protein localizes to the nucleus where it may form a homodimer or a heterodimer with estrogen receptor 2. Estrogen and its receptors are essential for sexual development and reproductive function, but also play a role in other tissues such as bone. Estrogen receptors are also involved in pathological processes including breast cancer, endometrial cancer, and osteoporosis. Alternative promoter usage and alternative splicing result in dozens of transcript variants, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Mar 2014]
Synonyms: ESR1 Antibody , ESRA Antibody , NR3A1 Antibody , ESR Antibody , estrogen receptor 1 Antibody , Era Antibody , ER Antibody
Cellular Localization:
CAS NO: 592542-60-4
Olcegepant
Host: Mouse
Clonality: Monoclonal
Isotype: IgG1
Immunogen: Recombinant human Estrogen Receptor alpha protein (aa2-185)
Antigen Species: Human
Species Reactivity: Human
Conjugation: Unconjugated
Storage Buffer: Prepared in 10mM PBS with 0.05% BSA and 0.05% azide.
Storage Instruction: Antibody with azide – store at 2 to 8°C. Antibody without azide – store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
Notes: For In vitro laboratory use only. Not for any clinical, therapeutic, or diagnostic use in humans or animals. Not for animal or human consumption.
Specificity: This MAb is specific to ER alpha and shows minimal cross-reaction with other members of the family. ER is an important regulator of growth and differentiation in the mammary gland. Presence of ER in breast tumors indicates an increased likelihood of response to anti-estrogen (e.g. tamoxifen) therapy. It strongly stains nuclei of epithelial cells in breast carcinomas.
PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/22679001?dopt=Abstract
